Identification Generic Name (2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE DrugBank Accession Number DB07145 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE (DB07145) ×  Close Weight Average: 433.4996  Monoisotopic: 433.200156367  Chemical Formula C 25 H 27 N 3 O 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Disintegrin and metalloproteinase domain-containing protein 17 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as phenylpyrrolidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrrolidine ring through a CC or CN bond. Pyrrolidine is a five-membered saturated aliphatic heterocycle with one nitrogen atom and four carbon atoms. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Pyrrolidines Sub Class Phenylpyrrolidines Direct Parent Phenylpyrrolidines Alternative Parents Quinolines and derivatives  /  Phenoxy compounds  /  Phenol ethers  /  Alkyl aryl ethers  /  Methylpyridines  /  Pyrrolidine-2-ones  /  N-alkylpyrrolidines  /  Tertiary carboxylic acid amides  /  Pyrroles  /  Heteroaromatic compounds  /  Lactams  /  Azacyclic compounds  /  Hydrocarbon derivatives  /  Organic oxides  /  Carbonyl compounds  /  Organonitrogen compounds  /  Organopnictogen compounds 
 
 
  show 7 more Substituents 2-pyrrolidone  /  3-phenylpyrrolidine  /  Alkyl aryl ether  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid derivative  /  Ether  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Lactam  /  Methylpyridine  /  Monocyclic benzene moiety  /  N-alkylpyrrolidine  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Phenol ether  /  Phenoxy compound  /  Pyridine  /  Pyrrole  /  Pyrrolidone  /  Quinoline  /  Tertiary carboxylic acid amide 
 
 
  show 19 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors quinolines, hydroxamic acid, pyrrolidin-2-ones ( CHEBI:40083 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key YDMIPBHQKFOFQW-NSYGIPOTSA-N InChI InChI=1S/C25H27N3O4/c1-16-14-18(21-6-4-5-7-22(21)26-16)15-32-20-10-8-19(9-11-20)25(3)12-13-28(24(25)30)17(2)23(29)27-31/h4-11,14,17,31H,12-13,15H2,1-3H3,(H,27,29)/t17-,25+/m1/s1 IUPAC Name (2R)-N-hydroxy-2-[(3S)-3-methyl-3-{4-[(2-methylquinolin-4-yl)methoxy]phenyl}-2-oxopyrrolidin-1-yl]propanamide SMILES [H][C@](C)(N1CC[C@](C)(C1=O)C1=CC=C(OCC2=CC(C)=NC3=CC=CC=C23)C=C1)C(=O)NO References General References Not Available External Links PubChem Compound 6914621 PubChem Substance 99443616 ChemSpider 5290501 BindingDB 26526 ChEBI 40083 ChEMBL CHEMBL148169 ZINC ZINC000003820969 PDBe Ligand 541 PDB Entries 2fv5 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00414 mg/mL ALOGPS logP 3.8 ALOGPS logP 2.97 Chemaxon logS -5 ALOGPS pKa (Strongest Acidic) 8.72 Chemaxon pKa (Strongest Basic) 5.02 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 91.76 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 120.08 m 3 ·mol -1 Chemaxon Polarizability 47.66 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9653 Blood Brain Barrier - 0.7125 Caco-2 permeable - 0.7048 P-glycoprotein substrate Substrate 0.7943 P-glycoprotein inhibitor I Non-inhibitor 0.5687 P-glycoprotein inhibitor II Inhibitor 0.9517 Renal organic cation transporter Non-inhibitor 0.7767 CYP450 2C9 substrate Non-substrate 0.8137 CYP450 2D6 substrate Non-substrate 0.7759 CYP450 3A4 substrate Substrate 0.7324 CYP450 1A2 substrate Non-inhibitor 0.8444 CYP450 2C9 inhibitor Inhibitor 0.5546 CYP450 2D6 inhibitor Non-inhibitor 0.7629 CYP450 2C19 inhibitor Non-inhibitor 0.5161 CYP450 3A4 inhibitor Inhibitor 0.7827 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7073 Ames test Non AMES toxic 0.5656 Carcinogenicity Non-carcinogens 0.7714 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.6764 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9785 hERG inhibition (predictor II) Inhibitor 0.5432    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 0.56 N/A N/A A30775 IC 50 (nM) 1 N/A N/A A30776  /  A30777 
 
 
  Details 
 
 
   Binding Properties 1.  Disintegrin and metalloproteinase domain-containing protein 17 Kind Protein Organism Humans Pharmacological action Unknown General Function Zinc ion binding Specific Function Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolyt... Gene Name ADAM17 Uniprot ID P78536 Uniprot Name Disintegrin and metalloproteinase domain-containing protein 17 Molecular Weight 93020.165 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:19 / Updated at June 12, 2020 16:52 